Effects of quercetin on inflammation and oxidative stress in COPD
Impact of quercetin on inflammatory and oxidative stress markers in COPD
This study is looking at how a natural compound called quercetin might help reduce inflammation and stress in the lungs of people with COPD, and it will check how safe it is and how well it works, so we can find better treatments for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10850913 on NIH RePORTER |
What this research studies
This research investigates how quercetin, a natural plant compound, can influence inflammation and oxidative stress in patients with chronic obstructive pulmonary disease (COPD). The study will assess the safety, bioavailability, and optimal dosing of quercetin while identifying biological markers that reflect clinical outcomes in COPD. By conducting this research in two phases, the team aims to gather essential data that could inform future clinical trials and improve treatment options for COPD patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD).
Not a fit: Patients with acute respiratory conditions or those not diagnosed with COPD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options that effectively reduce inflammation and oxidative stress in COPD patients.
How similar studies have performed: Previous studies have shown promising results with quercetin in other chronic lung diseases, indicating potential for success in this area as well.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Sajjan, Umadevi Sivanappa — Temple Univ of the Commonwealth
- Study coordinator: Sajjan, Umadevi Sivanappa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.